Physician profile
John G Spellman
NPI 1205937422
$30,437.03
in general payments reported to CMS, 2019-2025
35 companies · $1,672 in 2025
The $1,672 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $1,706 · 2021: $1,080 · 2022: $1,317 · 2023: $1,597 · 2024: $1,600 · 2025: $1,672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,869.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $13,544.10 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $9,220.62 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,383.96 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $1,052.75 | 2019-2025 | Farxiga, Lokelma |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $915.25 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $734.55 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $571.93 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $559.91 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $436.16 | 2022-2025 | Verquvo, Capvaxive |
| Cvrx, INC. | $336.93 | 2023-2025 | Barostim Neo System |
| Medtronic, INC. | $222.79 | 2021-2025 | Linq II, Aurora Ev-Icd Mri Surescan |
| Novo Nordisk INC | $145.40 | 2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $114.17 | 2021-2025 | |
| Abbott Laboratories | $110.51 | 2019 | |
| Cardiva Medical, INC. | $106.17 | 2024-2025 | Optowire, Savvywire |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $105.68 | 2019-2025 | Watchman Flx |
| Lexicon Pharmaceuticals, INC. | $92.42 | 2023-2024 | Inpefa |
| Philips North America LLC | $91.92 | 2020-2023 | |
| Alnylam Pharmaceuticals INC. | $87.96 | 2019-2025 | Onpattro |
| Sanofi-Aventis U.S. LLC | $86.29 | 2019-2024 | |
| Esperion Therapeutics, INC. | $74.77 | 2021-2025 | Nexletol |
| Medtronic Vascular, INC. | $55.14 | 2019-2020 | |
| Lantheus Medical Imaging, INC. | $55.13 | 2022-2023 | Definity |
| Kiniksa Pharmaceuticals, LTD. | $51.53 | 2022-2023 | Arcalyst |
| Elutia, INC. | $44.65 | 2019-2020 | |
| Astellas Pharma US INC | $42.92 | 2019-2020 | |
| Baxter Healthcare | $33.94 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Kiniksa Pharmaceuticals International, Plc | $33.53 | 2024 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $30.16 | 2019 | |
| Braemar Manufacturing, LLC | $22.93 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $16.97 | 2019 | |
| Celonova Biosciences, INC. | $15.47 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $14.91 | 2020 | |
| Medicomp INC | $13.02 | 2022 | |
| Bardy Diagnostics, INC. | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Spellman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.